Skip to main content
. 2023 Feb 15;324(4):E299–E313. doi: 10.1152/ajpendo.00307.2022

Figure 8.

Figure 8.

Modulation of hepatocellular redox, lipid oxidation and de novo lipogenesis by BCAAs. Chronic supplementation of BCAAs maintains hepatic insulin sensitivity while altering mitochondrial NADH:NAD+ ratio, activating fed-to-fasted phosphorylation of AMPKα and ACC. The higher NADH:NAD+ ratio and the activation of AMPKα primes the liver to oxidize free fatty acids, whereas the inhibitory phosphorylation of ACC helps downregulate DNL in the liver. BCAA, branched-chain amino acid.